FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ullamari Pesonen

Research Profile

Chemicals & Drugs

Disorders

Physiology

Living Beings

Co-author Network

Publications

TOP 3
Henriikka Salomäki; Laura H Vähätalo; Kirsti Laurila; Anna-Maija Penttinen; Ullamari Pesonen; Liisa Ailanen; Juan Ilyasizadeh; Norma T Jäppinen; Markku Koulu
Prenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthood.
Esa Kauppila; Salla Kaurijoki; Ullamari Pesonen; Kirsi H Pietiläinen; Aila Rissanen; Jari Tiihonen; Esko Vanninen; Leila J Karhunen; Jaakko Kaprio
Influence of serotonin transporter gene polymorphism (5-HTTLPR polymorphism) on the relation between brain 5-HT transporter binding and heart rate corrected cardiac repolarization interval.
Suvi T Ruohonen; Ullamari Pesonen; Eriika Savontaus
Neuropeptide Y in the noradrenergic neurons induces the development of cardiometabolic diseases in a transgenic mouse model.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ullamari Pesonen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Henriikka Salomäki; Laura H Vähätalo; Kirsti Laurila; Anna-Maija Penttinen; Ullamari Pesonen; Liisa Ailanen; Juan Ilyasizadeh; Norma T Jäppinen; Markku Koulu
Prenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthood.
PloS one 2013;8(2):e56594.
2013: Esa Kauppila; Salla Kaurijoki; Ullamari Pesonen; Kirsi H Pietiläinen; Aila Rissanen; Jari Tiihonen; Esko Vanninen; Leila J Karhunen; Jaakko Kaprio
Influence of serotonin transporter gene polymorphism (5-HTTLPR polymorphism) on the relation between brain 5-HT transporter binding and heart rate corrected cardiac repolarization interval.
PloS one 2013;8(1):e50303.
2012: Suvi T Ruohonen; Ullamari Pesonen; Eriika Savontaus
Neuropeptide Y in the noradrenergic neurons induces the development of cardiometabolic diseases in a transgenic mouse model.
Indian journal of endocrinology and metabolism 2012;16(Suppl 3):S569-76.
2012: Nora Hagelberg; Jarmo Hietala; Sargo Aalto; Kjell Någren; Antti Pertovaara; Ullamari Pesonen; Harry Scheinin; Lauri Tuominen; Ilkka K Martikainen
Striatal μ-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects.
Neuroscience letters 2012;521(1):11-4.
2010: Mikko Joensuu; Soili Marianne Lehto; Tommi Tolmunen; Pirjo Irmeli Saarinen; Minna Valkonen-Korhonen; Ritva Vanninen; Pasi Ahola; Jari Tiihonen; Jyrki Kuikka; Ullamari Pesonen; Johannes Lehtonen
Serotonin-transporter-linked promoter region polymorphism and serotonin transporter binding in drug-naïve patients with major depression.
Psychiatry and clinical neurosciences 2010;64(4):387-93.
2010: Mika M Hirvonen; Kjell Någren; Juha O Rinne; Ullamari Pesonen; Tero Vahlberg; Nora Hagelberg; Jarmo Hietala
COMT Val158Met genotype does not alter cortical or striatal dopamine D2 receptor availability in vivo.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2010;12(2):192-7.
2010: Sanna Vähämiko; Erika Isolauri; Ullamari Pesonen; Pertti Koskinen; Ulla Ekblad; Kirsi Laitinen
Dietary sucrose intake is related to serum leptin concentration in overweight pregnant women.
European journal of nutrition 2010;49(2):83-90.
2009: Katja Kaipio; Jaana Kallio; Ullamari Pesonen
The effect of endogenous preproneuropeptide Y leucine 7 to proline 7 polymorphism on growth and apoptosis in primary cultured HUVECs.
Biological chemistry 2009;390(9):899-905.
2009: Ilkka K Martikainen; Jussi Hirvonen; Ullamari Pesonen; Nora Hagelberg; Heikki Laurikainen; Heikki Tuikkala; Jaana Kajander; Kjell Någren; Jarmo Hietala; Antti Pertovaara
Differential associations between brain 5-HT(1A) receptor binding and response to pain versus touch.
Journal of neural transmission (Vienna, Austria : 1996) 2009;116(7):821-30.
2009: Mika M Hirvonen; Ville Lumme; Jussi Hirvonen; Ullamari Pesonen; Kjell Någren; Tero Vahlberg; Harry Scheinin; Jarmo Hietala
C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo.
Progress in neuro-psychopharmacology & biological psychiatry 2009;33(4):630-6.
2009: Katja Kaipio; Tero Vahlberg; Marianne Suominen; Ullamari Pesonen
The role of non-synonymous NPY gene polymorphism in the nitric oxide production in HUVECs.
Biochemical and biophysical research communications 2009;381(4):587-91.
2009: Suvi T Ruohonen; Ken Abe; Mia Kero; Laura Toukola; Saku Ruohonen; Matias Röyttä; Markku Koulu; Ullamari Pesonen; Zofia Zukowska; Eriika Savontaus
Sympathetic nervous system-targeted neuropeptide Y overexpression in mice enhances neointimal formation in response to vascular injury.
Peptides 2009;30(4):715-20.
2009: Katja Kaipio; Ullamari Pesonen
The intracellular mobility of NPY and a putative mitochondrial form of NPY in neuronal cells.
Neuroscience letters 2009;450(2):181-5.
2009: Suvi T Ruohonen; Eriika Savontaus; Petteri Rinne; Joana Rosmaninho-Salgado; Claudia Cavadas; Heikki Ruskoaho; Markku Koulu; Ullamari Pesonen
Stress-induced hypertension and increased sympathetic activity in mice overexpressing neuropeptide Y in noradrenergic neurons.
Neuroendocrinology 2009;89(3):351-60.
2008: Ullamari Pesonen
NPY L7P polymorphism and metabolic diseases.
Regulatory peptides 2008;149(1-3):51-5.
2008: Salla Kaurijoki; Jyrki T Kuikka; Eini Niskanen; Synnöve Carlson; Kirsi H Pietiläinen; Ullamari Pesonen; Jaakko Kaprio; Aila Rissanen; Jari Tiihonen; Leila J Karhunen
Association of serotonin transporter promoter regulatory region polymorphism and cerebral activity to visual presentation of food.
Clinical physiology and functional imaging 2008;28(4):270-6.
2008: Suvi T Ruohonen; Ullamari Pesonen; Niko Moritz; Katja Kaipio; Matias Röyttä; Markku Koulu; Eriika Savontaus
Transgenic mice overexpressing neuropeptide Y in noradrenergic neurons: a novel model of increased adiposity and impaired glucose tolerance.
Diabetes 2008;57(6):1517-25.
2008: Anu K Koskela; Salla Kaurijoki; Kirsi H Pietiläinen; Leila J Karhunen; Ullamari Pesonen; Jyrki T Kuikka; Jaakko Kaprio; Aila Rissanen
Serotonin transporter binding and acquired obesity -- an imaging study of monozygotic twin pairs.
Physiology & behavior 2008;93(4-5):724-32.
2007: Ulriikka Jaakkola; Markku Koulu; Matti K Karvonen; H Seppälä; Ullamari Pesonen; Tero Vahlberg; Jaana Kallio
Impact of the Leu7Pro polymorphism of preproNPY on diurnal NPY and hormone secretion in type 2 diabetes.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2007;115(5):281-6.
2007: Kai Kaarniranta; Juha M Holopainen; Matti K Karvonen; Markku Koulu; Jaana Kallio; Ullamari Pesonen; Markku Teräsvirta; Hannu Uusitalo; Ilkka Immonen
Leucine 7-proline 7 polymorphism in the signal peptide of neuropeptide Y is not a risk factor for exudative age-related macular degeneration.
Acta ophthalmologica Scandinavica 2007;85(2):188-91.
2006: Matti K Karvonen; Soile Ruottinen; Markku Koulu; Ullamari Pesonen; Harri Niinikoski; Leena Rask-Nissilä; Olli Simell; Tapani Rönnemaa
Nutrient intake, weight, and Leu7Pro polymorphism in prepro-neuropeptide Y in children.
The Journal of clinical endocrinology and metabolism 2006;91(11):4664-8.
2006: Ulriikka Jaakkola; Ullamari Pesonen; Elina Vainio-Jylhä; Markku Koulu; M Pöllönen; Jaana Kallio
The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic retinopathy.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2006;114(4):147-52.
2006: Ullamari Pesonen
Human NPY gene variants in cardiovascular and metabolic diseases.
EXS 2006;(95):247-67.
2005: Katja Kaipio; Jaana Kallio; Ullamari Pesonen
Mitochondrial targeting signal in human neuropeptide Y gene.
Biochemical and biophysical research communications 2005;337(2):633-40.
2005: Ulriikka Jaakkola; Tom A Kuusela; Tuomas Jartti; Ullamari Pesonen; Markku Koulu; Tero Vahlberg; Jaana Kallio
The Leu7Pro polymorphism of preproNPY is associated with decreased insulin secretion, delayed ghrelin suppression, and increased cardiovascular responsiveness to norepinephrine during oral glucose tolerance test.
The Journal of clinical endocrinology and metabolism 2005;90(6):3646-52.
2004: Saila Antila; Ullamari Pesonen; Lasse Lehtonen; Pasi Tapanainen; Hanna Nikkanen; Katja Vaahtera; Harry Scheinin
Pharmacokinetics of levosimendan and its active metabolite OR-1896 in rapid and slow acetylators.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2004;23(3):213-22.
2004: Maciej Tomaszewski; Fadi J Charchar; Beata Lacka; Ullamari Pesonen; William Y S Wang; Ewa Zukowska-Szczechowska; Wladyslaw Grzeszczak; Anna F Dominiczak
Epistatic interaction between beta2-adrenergic receptor and neuropeptide Y genes influences LDL-cholesterol in hypertension.
Hypertension 2004;44(5):689-94.
2004: Anna-Mari Heikkinen; Leo Niskanen; Jukka A Salmi; Markku Koulu; Ullamari Pesonen; M I J Uusitupa; Marja Komulainen; Marjo Tuppurainen; Heikki Kröger; Jukka S Jurvelin; Seppo Saarikoski
Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
Bone 2004;35(3):589-94.
2004: Cécile Cayla; Petri Heinonen; Liisa Viikari; Stéphane Schaak; Amir Snapir; Anne Bouloumié; Matti K Karvonen; Ullamari Pesonen; Mika Scheinin; Hervé Paris
Cloning, characterisation and identification of several polymorphisms in the promoter region of the human alpha2B-adrenergic receptor gene.
Biochemical pharmacology 2004;67(3):469-78.
2004: Kim Pettersson-Fernholm; Matti K Karvonen; Jaana Kallio; Carol Forsblom; Markku Koulu; Ullamari Pesonen; Johan Fagerudd; Per-Henrik Groop
Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients.
Diabetes care 2004;27(2):503-9.
2004: Markku Koulu; Sharareh Movafagh; Jukka Tuohimaa; Ulriikka Jaakkola; Jaana Kallio; Ullamari Pesonen; Yixun Geng; Matti K Karvonen; Elina Vainio-Jylhä; Matti Pöllönen; Katja Kaipio-Salmi; Helena Seppälä; Edward W Lee; Rosemary D Higgins; Zofia Zukowska
Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization.
Annals of medicine 2004;36(3):232-40.
2003: Jukka Kero; Eriika Savontaus; Maarit Mikola; Ullamari Pesonen; Markku Koulu; Ruth A Keri; John H Nilson; Matti Poutanen; Ilpo T Huhtaniemi
Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion.
American journal of physiology. Endocrinology and metabolism 2003;285(4):E812-8.
2003: Jaana Kallio; Ullamari Pesonen; Ulriikka Jaakkola; Matti K Karvonen; Hans Helenius; Markku Koulu
Changes in diurnal sympathoadrenal balance and pituitary hormone secretion in subjects with Leu7Pro polymorphism in the prepro-neuropeptide Y.
The Journal of clinical endocrinology and metabolism 2003;88(7):3278-83.
2003: Ullamari Pesonen; Werner Koch; Albert Schömig; Adnan Kastrati
Leucine 7 to proline 7 polymorphism of the preproneuropeptide Y gene is not associated with restenosis after coronary stenting.
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2003;10(3):566-72.
2003: Jussi Pihlajamäki; Pauli Karhapää; Ilkka Vauhkonen; Päivi Kekäläinen; Anu Kareinen; Laura Viitanen; Ullamari Pesonen; Jaana Kallio; Matti Uusitupa; Markku Laakso
The Leu7Pro polymorphism of the neuropeptide Y gene regulates free fatty acid metabolism.
Metabolism: clinical and experimental 2003;52(5):643-6.
2003: Mikko J Järvisalo; Laura Jartti; Matti K Karvonen; Ullamari Pesonen; Markku Koulu; Jukka Marniemi; Niklas Hammar; Jaakko Kaprio; Ulla Paakkunainen; Olli Simell; Olli T Raitakari; Tapani Rönnemaa
Enhanced endothelium-dependent vasodilation in subjects with Proline7 substitution in the signal peptide of neuropeptide Y.
Atherosclerosis 2003;167(2):319-26.
2002: Petri Heinonen; Laura Jartti; Mikko J Järvisalo; Ullamari Pesonen; Jaakko Kaprio; Tapani Rönnemaa; Olli T Raitakari; Mika Scheinin
Deletion polymorphism in the alpha2B-adrenergic receptor gene is associated with flow-mediated dilatation of the brachial artery.
Clinical science (London, England : 1979) 2002;103(5):517-24.
2002: Moonseong Heo; Rudolph L Leibel; Kevin R Fontaine; Bert Boyer; Wendy Chung; Markku Koulu; Matti K Karvonen; Ullamari Pesonen; Aila Rissanen; M Laakso; M I J Uusitupa; Y Chagnon; C Bouchard; Patricia A Donohoue; T L Burns; Alan R Shuldiner; Kristi D Silver; Ross E Andersen; O Pedersen; Søren M Echwald; Thorkild I A Sørensen; PS Behn; M A Permutt; K B Jacobs; R C Elston; D J Hoffman; E Gropp; David Allison
A meta-analytic investigation of linkage and association of common leptin receptor (LEPR) polymorphisms with body mass index and waist circumference.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2002;26(5):640-6.
2002: Ursula S Schwab; Jyrki J Agren; RH Valve; Merja Hallikainen; Essi S Sarkkinen; M Jauhiainen; Matti K Karvonen; Ullamari Pesonen; Markku Koulu; M I J Uusitupa; Markku Savolainen
The impact of the leucine 7 to proline 7 polymorphism of the neuropeptide Y gene on postprandial lipemia and on the response of serum total and lipoprotein lipids to a reduced fat diet.
European journal of clinical nutrition 2002;56(2):149-56.
2001: Moonseong Heo; Rudolph L Leibel; Bert Boyer; Wendy Chung; Markku Koulu; Matti K Karvonen; Ullamari Pesonen; Aila Rissanen; M Laakso; M I J Uusitupa; Y Chagnon; C Bouchard; Patricia A Donohoue; T L Burns; Alan R Shuldiner; Kristi D Silver; Ross E Andersen; O Pedersen; Søren M Echwald; Thorkild I A Sørensen; PS Behn; M A Permutt; K B Jacobs; R C Elston; D J Hoffman; David Allison
Pooling analysis of genetic data: the association of leptin receptor (LEPR) polymorphisms with variables related to human adiposity.
Genetics 2001;159(3):1163-78.
2001: Jaana Kallio; Ullamari Pesonen; Matti K Karvonen; M Kojima; H Hosoda; K Kangawa; Markku Koulu
Enhanced exercise-induced GH secretion in subjects with Pro7 substitution in the prepro-NPY.
The Journal of clinical endocrinology and metabolism 2001;86(11):5348-52.
2001: Matti K Karvonen; Veli-Pekka Valkonen; Timo A Lakka; Riitta Salonen; Markku Koulu; Ullamari Pesonen; Tomi-Pekka Tuomainen; Jussi Kauhanen; Kristiina Nyyssönen; Hanna-Maaria Lakka; M I J Uusitupa; Jukka T Salonen
Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men.
Atherosclerosis 2001;159(1):145-51.
2001: Amir Snapir; Petri Heinonen; Tomi-Pekka Tuomainen; P Alhopuro; Matti K Karvonen; Timo A Lakka; Kristiina Nyyssönen; Riitta Salonen; Jussi Kauhanen; Veli-Pekka Valkonen; Ullamari Pesonen; Markku Koulu; Mika Scheinin; Jukka T Salonen
An insertion/deletion polymorphism in the alpha2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events.
Journal of the American College of Cardiology 2001;37(6):1516-22.
2001: Jaana Kallio; Ullamari Pesonen; K Kaipio; Matti K Karvonen; Ulriikka Jaakkola; Olli Heinonen; M I J Uusitupa; Markku Koulu
Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(7):1242-4.
2001: V Luukkaa; Eriika Savontaus; Juha Rouru; Kirsi A Virtanen; Olivier Boss; Ilpo Huhtaniemi; Markku Koulu; Ullamari Pesonen; Risto Huupponen
Effects of estrous cycle and steroid replacement on the expression of leptin and uncoupling proteins in adipose tissue in the rat.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2001;15(2):103-12.
2000: Jussi Kauhanen; Matti K Karvonen; Ullamari Pesonen; Markku Koulu; Tomi-Pekka Tuomainen; M I J Uusitupa; Jukka T Salonen
Neuropeptide Y polymorphism and alcohol consumption in middle-aged men.
American journal of medical genetics 2000;93(2):117-21.
2000: Jari Tiihonen; Ullamari Pesonen; Jussi Kauhanen; Markku Koulu; Tero Hallikainen; L Leskinen; Jukka T Salonen
CYP2A6 genotype and smoking.
Molecular psychiatry 2000;5(4):347-8.
2000: Seppo Helisalmi; RH Valve; Matti K Karvonen; Mikko Hiltunen; Mia Pirskanen; Arto Mannermaa; Markku Koulu; Ullamari Pesonen; Matti Uusitupa; Hilkka Soininen
The leucine (7)-to-proline (7) polymorphism in the signal peptide of neuropeptide Y is not associated with Alzheimer's disease or the link apolipoprotein E.
Neuroscience letters 2000;287(1):25-8.
2000: Leo Niskanen; Matti K Karvonen; RH Valve; Markku Koulu; Ullamari Pesonen; M Mercuri; Rainer Rauramaa; Jari Töyry; Markku Laakso; M I J Uusitupa
Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects.
The Journal of clinical endocrinology and metabolism 2000;85(6):2266-9.
2000: Mirja Somer; Jaana Kallio; Ullamari Pesonen; K Pyykkö; Risto Huupponen; Mika Scheinin
Influence of hydroxychloroquine on the bioavailability of oral metoprolol.
British journal of clinical pharmacology 2000;49(6):549-54.
2000: Matti K Karvonen; Markku Koulu; Ullamari Pesonen; M I J Uusitupa; Anne Tammi; Jorma Viikari; Olli Simell; Tapani Rönnemaa
Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool aged children.
The Journal of clinical endocrinology and metabolism 2000;85(4):1455-60.
2000: Eriika Savontaus; Juha Rouru; Kimmo Malminiemi; V Luukkaa; Ullamari Pesonen; Markku Koulu; Risto Huupponen
Effects of chronic celiprolol treatment on brown fat, feeding, and drinking in fa/fa Zucker rats.
Pharmacology, biochemistry, and behavior 2000;65(4):719-24.
2000: Leo Niskanen; Raija Voutilainen-Kaunisto; Markku Teräsvirta; Matti K Karvonen; RH Valve; Ullamari Pesonen; Markku Laakso; M I J Uusitupa; Markku Koulu
Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in type 2 diabetes.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2000;108(3):235-6.
1999: Petri Heinonen; Markku Koulu; Ullamari Pesonen; Matti K Karvonen; Aila Rissanen; Markku Laakso; RH Valve; Matti Uusitupa; Mika Scheinin
Identification of a three-amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects.
The Journal of clinical endocrinology and metabolism 1999;84(7):2429-33.
1999: M I Uusitupa; M K Karvonen; Ullamari Pesonen; Markku Koulu
[Neuropeptide Y and serum cholesterol].
Duodecim; lääketieteellinen aikakauskirja 1999;115(3):241-2.
1998: M I Uusitupa; Matti K Karvonen; Ullamari Pesonen; Markku Koulu
Neuropeptide Y: a novel link between the neuroendocrine system and cholesterol metabolism.
Annals of medicine 1998;30(6):508-10.
1998: Matti K Karvonen; Ullamari Pesonen; Markku Koulu; L Niskanen; M Laakso; Aila Rissanen; J M Dekker; L M Hart; RH Valve; M I J Uusitupa
Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels.
Nature medicine 1998;4(12):1434-7.
1998: V Luukkaa; Ullamari Pesonen; Ilpo Huhtaniemi; A Lehtonen; R Tilvis; Jaakko Tuomilehto; Markku Koulu; Risto Huupponen
Inverse correlation between serum testosterone and leptin in men.
The Journal of clinical endocrinology and metabolism 1998;83(9):3243-6.
1998: Matti K Karvonen; Ullamari Pesonen; Petri Heinonen; Markku Laakso; Aila Rissanen; Hannu Naukkarinen; RH Valve; M I J Uusitupa; Markku Koulu
Identification of new sequence variants in the leptin gene.
The Journal of clinical endocrinology and metabolism 1998;83(9):3239-42.
1998: Eriika Savontaus; Ullamari Pesonen; Juha Rouru; Risto Huupponen; Markku Koulu
Effects of ZD7114, a selective beta3-adrenoceptor agonist, on neuroendocrine mechanisms controlling energy balance.
European journal of pharmacology 1998;347(2-3):265-74.
1998: Ullamari Pesonen; Markku Koulu; A Bergen; M Eggert; Hannu Naukkarinen; Matti Virkkunen; Markku Linnoila; David Goldman
Mutation screening of the 5-hydroxytryptamine7 receptor gene among Finnish alcoholics and controls.
Psychiatry research 1998;77(3):139-45.
1997: Eriika Savontaus; A Raasmaja; Juha Rouru; Markku Koulu; Ullamari Pesonen; Raine Virtanen; Juha-Matti Savola; Risto Huupponen
Anti-obesity effect of MPV-1743 A III, a novel imidazoline derivative, in genetic obesity.
European journal of pharmacology 1997;328(2-3):207-15.
1996: N Ozaki; Norman Rosenthal; Ullamari Pesonen; J Lappalainen; Susana Feldman-Naim; Paul J Schwartz; Erick H Turner; David Goldman
Two naturally occurring amino acid substitutions of the 5-HT2A receptor: similar prevalence in patients with seasonal affective disorder and controls.
Biological psychiatry 1996;40(12):1267-72.
1995: Juha Rouru; Markku Koulu; Juha Peltonen; E Santti; V Hänninen; Ullamari Pesonen; Risto Huupponen
Effects of metformin treatment on glucose transporter proteins in subcellular fractions of skeletal muscle in (fa/fa) Zucker rats.
British journal of pharmacology 1995;115(7):1182-7.
1995: Juha Rouru; Ullamari Pesonen; Markku Koulu; Risto Huupponen; E Santti; K Virtanen; T Rouvari; M Jhanwar-Uniyal
Anorectic effect of metformin in obese Zucker rats: lack of evidence for the involvement of neuropeptide Y.
European journal of pharmacology 1995;273(1-2):99-106.
1994: E Santti; Risto Huupponen; Juha Rouru; V Hänninen; Ullamari Pesonen; M Jhanwar-Uniyal; Markku Koulu
Potentiation of the anti-obesity effect of the selective beta 3-adrenoceptor agonist BRL 35135 in obese Zucker rats by exercise.
British journal of pharmacology 1994;113(4):1231-6.
1994: Oskari Heikinheimo; Ullamari Pesonen; R Huupponen; Markku Koulu; Pekka Lähteenmäki
Hepatic metabolism and distribution of mifepristone and its metabolites in rats.
Human reproduction (Oxford, England) 1994;9 Suppl 1():40-6.
1994: Ullamari Pesonen; Markku Koulu
[Brain neurochemical systems which control appetite].
Duodecim; lääketieteellinen aikakauskirja 1994;110(13):1241-50.
1993: Juha Rouru; Ullamari Pesonen; K Isaksson; Risto Huupponen; Markku Koulu
Effect of chronic treatment with TFMPP, a 5-HT1 receptor agonist, on food intake, weight gain, plasma insulin and neuropeptide mRNA expression in obese Zucker rats.
European journal of pharmacology 1993;234(2-3):191-8.
1993: Markku Koulu; Ullamari Pesonen; S Koskinen; Harry Scheinin; Raine Virtanen; Mika Scheinin
Reduced turnover of dopamine and 5-hydroxytryptamine in discrete dopaminergic, noradrenergic and serotonergic rat brain areas after acutely administered medetomidine, a selective alpha 2-adrenoceptor agonist.
Pharmacology & toxicology 1993;72(3):182-7.
1992: Ullamari Pesonen; Risto Huupponen; Juha Rouru; Markku Koulu
Hypothalamic neuropeptide expression after food restriction in Zucker rats: evidence of persistent neuropeptide Y gene activation.
Brain research. Molecular brain research 1992;16(3-4):255-60.
1992: Ullamari Pesonen; J Jolkkonen; Risto Huupponen; Markku Koulu
Differential hypothalamic arginine vasopressin response to glucocorticoid receptor antagonism in lean and obese Zucker rats.
Neuroendocrinology 1992;56(2):271-7.
1992: Ullamari Pesonen; T Miettinen; Mika Scheinin; Markku Koulu
Alpha 2-adrenoceptor density in forebrain areas of Zucker rats: no effect of genetic obesity or antiglucocorticoid treatment.
Brain research 1992;574(1-2):353-6.
1992: Ullamari Pesonen; Markku Koulu; Oskari Heikinheimo; Risto Huupponen
The glucocorticoid antagonist mifepristone reveals abnormal regulation of the adrenocortical system in obese Zucker rats.
The Journal of endocrinology 1992;132(3):425-31.
1992: Juha Rouru; Risto Huupponen; Ullamari Pesonen; Markku Koulu
Subchronic treatment with metformin produces anorectic effect and reduces hyperinsulinemia in genetically obese Zucker rats.
Life sciences 1992;50(23):1813-20.
1991: Ullamari Pesonen; Juha Rouru; Risto Huupponen; Markku Koulu
Effects of repeated administration of mifepristone and 8-OH-DPAT on expression of preproneuropeptide Y mRNA in the arcuate nucleus of obese Zucker rats.
Brain research. Molecular brain research 1991;10(3):267-72.
1991: M A Päivärinta; Reijo J Marttila; Markku Koulu; Ullamari Pesonen; Matias Röyttä; UK Rinne
Brain monoamine metabolism and rotational behaviour induced by experimental herpes simplex virus encephalitis.
Journal of neural transmission. General section 1991;86(3):181-90.
1990: Risto Huupponen; Markku Koulu; Ullamari Pesonen
Hypothalamic 5-hydroxytryptamine metabolism is not influenced by streptozotocin-diabetes induced at neonatal age.
Experimental and clinical endocrinology 1990;96(3):328-30.
1990: Markku Koulu; Risto Huupponen; H Hänninen; Ullamari Pesonen; Juha Rouru; T Seppälä
Hypothalamic neurochemistry and feeding behavioral responses to clonidine, an alpha-2-agonist, and to trifluoromethylphenylpiperazine, a putative 5-hydroxytryptamine-1B agonist, in genetically obese Zucker rats.
Neuroendocrinology 1990;52(5):503-10.
1990: Esa-Matti Lilius; Ullamari Pesonen
Use of inflammatory cell activities in bovine milk to diagnose mastitis.
American journal of veterinary research 1990;51(10):1527-33.
1990: Markku Koulu; Ullamari Pesonen; Raine Virtanen
Chronic dexmedetomidine, a selective alpha 2-agonist, decreases serotonin but not noradrenaline turnover in rat brainstem nuclei.
European journal of pharmacology 1990;176(2):151-7.
1988: Markku Koulu; J Lappalainen; Ullamari Pesonen; Jarmo Hietala; Erkka Syvälahti
Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus.
European journal of pharmacology 1988;155(3):313-6.